191 related articles for article (PubMed ID: 11028454)
1. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients.
Carrascosa A; Gussinyé M; Terradas P; Yeste D; Audí L; Vicens-Calvet E
J Bone Miner Res; 2000 Oct; 15(10):2005-10. PubMed ID: 11028454
[TBL] [Abstract][Full Text] [Related]
2. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
Costa AM; Lemos-Marini SH; Baptista MT; Morcillo AM; Maciel-Guerra AT; Guerra G
J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
[TBL] [Abstract][Full Text] [Related]
3. Low areal bone mineral density values in adolescents and young adult turner syndrome patients increase after long-term transdermal estradiol therapy.
Gussinyé M; Terrades P; Yeste D; Vicens-Calvet E; Carrascosa A
Horm Res; 2000; 54(3):131-5. PubMed ID: 11357006
[TBL] [Abstract][Full Text] [Related]
4. The effect of growth hormone treatment on bone mineral density in prepubertal girls with Turner syndrome: a multicentre prospective clinical trial.
Aycan Z; Cetinkaya E; Darendeliler F; Vidinlisan S; Bas F; Bideci A; Demirel F; Darcan S; Buyukgebiz A; Yildiz M; Berberoglu M; Bundak R
Clin Endocrinol (Oxf); 2008 May; 68(5):769-72. PubMed ID: 17980015
[TBL] [Abstract][Full Text] [Related]
5. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
6. [The effect of primary lack of estrogens and the influence of the age at the beginning of estrogen therapy on bone mineral density in patients with Turner's syndrome].
Sowińska-Przepiera E; Andrysiak-Mamos E; Friebe Z; Kapczuk K; Pilarska K
Endokrynol Pol; 2005; 56(2):145-53. PubMed ID: 16335682
[TBL] [Abstract][Full Text] [Related]
7. Gradually increasing ethinyl estradiol for Turner syndrome may produce good final height but not ideal BMD.
Hasegawa Y; Ariyasu D; Izawa M; Igaki-Miyamoto J; Fukuma M; Hatano M; Yagi H; Goto M
Endocr J; 2017 Feb; 64(2):221-227. PubMed ID: 27916781
[TBL] [Abstract][Full Text] [Related]
8. Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry.
Högler W; Briody J; Moore B; Garnett S; Lu PW; Cowell CT
J Clin Endocrinol Metab; 2004 Jan; 89(1):193-9. PubMed ID: 14715849
[TBL] [Abstract][Full Text] [Related]
9. Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.
Quigley CA; Wan X; Garg S; Kowal K; Cutler GB; Ross JL
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1754-64. PubMed ID: 24762109
[TBL] [Abstract][Full Text] [Related]
10. [Optimizing estrogen treatment in Turner syndrome].
Ságodi L; Sólyom E
Orv Hetil; 2003 Mar; 144(12):563-8. PubMed ID: 12723527
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner's syndrome participating in a randomized dose-response study.
Sas TC; de Muinck Keizer-Schrama SM; Stijnen T; van Teunenbroek A; van Leeuwen WJ; Asarfi A; van Rijn RR; Drop SL;
Pediatr Res; 2001 Sep; 50(3):417-22. PubMed ID: 11518831
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial.
Sass TC; De Muinck Keizer-Schrama SM; Stijnen T; Asarfi A; Van Leeuwen WJ; Van Teunenbroek A; Van Rijn RR; Drop SL
Clin Endocrinol (Oxf); 2000 May; 52(5):531-6. PubMed ID: 10792330
[TBL] [Abstract][Full Text] [Related]
13. Turner syndrome adolescents receiving growth hormone are not osteopenic.
Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
[TBL] [Abstract][Full Text] [Related]
14. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome.
Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P
J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126
[TBL] [Abstract][Full Text] [Related]
15. Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height.
Massa G; Heinrichs C; Verlinde S; Thomas M; Bourguignon JP; Craen M; François I; Du Caju M; Maes M; De Schepper J;
J Clin Endocrinol Metab; 2003 Sep; 88(9):4168-74. PubMed ID: 12970282
[TBL] [Abstract][Full Text] [Related]
16. [Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis].
Lurati A; Cimaz R; Gattinara M; Gerloni V; Teruzzi B; Salmaso A; Fantini F
Reumatismo; 2008; 60(3):224-9. PubMed ID: 18854886
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
Theintz G; Buchs B; Rizzoli R; Slosman D; Clavien H; Sizonenko PC; Bonjour JP
J Clin Endocrinol Metab; 1992 Oct; 75(4):1060-5. PubMed ID: 1400871
[TBL] [Abstract][Full Text] [Related]
18. Near Adult Height in Girls with Turner Syndrome Treated with Growth Hormone Following Either Induced or Spontaneous Puberty.
Lanes R; Lindberg A; Carlsson M; Chrysis D; Aydin F; Camacho-Hübner C; King D; Davenport M
J Pediatr; 2019 Sep; 212():172-179.e1. PubMed ID: 31227282
[TBL] [Abstract][Full Text] [Related]
19. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
Cacciari E; Mazzanti L
J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
[TBL] [Abstract][Full Text] [Related]
20. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass.
Saggese G; Baroncelli GI; Bertelloni S; Barsanti S
J Clin Endocrinol Metab; 1996 Aug; 81(8):3077-83. PubMed ID: 8768878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
